Trademark search for:

LATHAMIZED NAD+

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2021-08-31 — Application filed
2021-09-03 — Application filed
2021-10-14 — Application filed
2022-06-04 — Assigned to examiner
2022-06-08 — Final disposition recorded
2022-06-08 — Final disposition recorded
2022-06-08 — Final disposition recorded
2023-01-11 — Application abandoned
2023-01-11 — Application abandoned
2023-01-11 — Office action issued
2023-01-11 — Application abandoned
2023-01-11 — Petition to revive-granted
2023-01-11 — Teas petition to revive received
2023-01-12 — Notice of revival - e-mailed
2023-03-29 — Teas/email correspondence entered
2023-03-29 — Assigned to lie
2023-03-29 — Correspondence received in law office
2023-04-03 — Approved for pub - principal register
2023-04-19 — Notification of notice of publication e-mailed
2023-05-09 — Published for opposition
2023-05-09 — Official gazette publication confirmation e-mailed
2023-07-04 — Noa e-mailed - sou required from applicant
2024-02-05 — Application abandoned
2024-02-05 — Application abandoned
2024-02-05 — Final status recorded

Owner Information

BioNADrx Holdings, Inc.
Hendersonville , TN

Correspondent

Michael D. Eisenberg MDE PATENTS
1991 VILLAGE PARK WAY, SUITE 202C
ENCINITAS, CA 92024
UNITED STATES

Filing Details

Filing Date:
2021-08-31

Status Date:
2024-02-05

Category:
Pharmaceuticals

Filing Year:
2021

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.